Ligand · TK5
TK5 · 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide
TK5, 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide (C34 H45 N7 O5 S, 663.8 g/mol), in the MolNFT structures on…
- Component
- TK5
- Formula
- C34 H45 N7 O5 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
TK5 in 2 structures; the first of them:
- 7BE4 · Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR159 · TK5 A401 · binds VAL30, TYR35, VAL38, ALA51, LYS53, ARG70, GLU71, LEU74 and 18 more
- 7BE4 · Crystal structure of MAP kinase P38 alpha in complex with inhibitor SR159 · TK5 A401 · binds VAL30, TYR35, VAL38, ALA51, LYS53, ARG70, GLU71, LEU74 and 18 more
Residues it binds most
LEU 2, ILE 2, VAL 2, ALA 2, GLY 2, HIS 2, MET 2, ARG 2, ASP 2, GLU 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.